Mathieu Boulin

946 total citations
57 papers, 676 citations indexed

About

Mathieu Boulin is a scholar working on Hepatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mathieu Boulin has authored 57 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 15 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Mathieu Boulin's work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer Mechanisms and Therapy (9 papers) and Pharmaceutical Practices and Patient Outcomes (7 papers). Mathieu Boulin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer Mechanisms and Therapy (9 papers) and Pharmaceutical Practices and Patient Outcomes (7 papers). Mathieu Boulin collaborates with scholars based in France, United States and New Zealand. Mathieu Boulin's co-authors include Boris Guiu, Jean–Pierre Cercueil, Patrick Hillon, Laurent Bedenne, Serge Aho, Bruno Chauffert, Maëva Wendremaire, Philippe Fagnoni, Côme Lepage and Yves Cottin and has published in prestigious journals such as PLoS ONE, Radiology and Journal of Hepatology.

In The Last Decade

Mathieu Boulin

51 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathieu Boulin France	17	320	140	123	116	102	57	676
Arben Lleshi Italy	18	131 0.4×	420 3.0×	161 1.3×	214 1.8×	108 1.1×	49	880
Virginia Clark United States	20	643 2.0×	264 1.9×	742 6.0×	103 0.9×	142 1.4×	57	1.4k
Philippe Fagnoni France	11	102 0.3×	61 0.4×	49 0.4×	47 0.4×	45 0.4×	36	295
Y. Shima Japan	14	417 1.3×	180 1.3×	181 1.5×	61 0.5×	183 1.8×	25	954
José Luís Poveda Spain	18	34 0.1×	199 1.4×	79 0.6×	88 0.8×	65 0.6×	90	922
Judy L. Chase United States	13	455 1.4×	304 2.2×	93 0.8×	41 0.4×	135 1.3×	16	781
Nicole Engel-Nitz United States	13	44 0.1×	147 1.1×	208 1.7×	42 0.4×	103 1.0×	40	767
Viktor Chirikov United States	14	110 0.3×	66 0.5×	203 1.7×	79 0.7×	66 0.6×	59	482
Annette Conrads‐Frank United States	11	79 0.2×	64 0.5×	98 0.8×	23 0.2×	27 0.3×	38	476
A. Burak Ozbay United States	16	222 0.7×	210 1.5×	337 2.7×	116 1.0×	162 1.6×	89	809

Countries citing papers authored by Mathieu Boulin

Since Specialization

Citations

This map shows the geographic impact of Mathieu Boulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Boulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Boulin more than expected).

Fields of papers citing papers by Mathieu Boulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Boulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Boulin. The network helps show where Mathieu Boulin may publish in the future.

Co-authorship network of co-authors of Mathieu Boulin

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Boulin. A scholar is included among the top collaborators of Mathieu Boulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Boulin. Mathieu Boulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schmitt, Antonin, et al.. (2024). The harms of inappropriate digoxin prescribing in cancer patients: A drug-drug interaction with posaconazole. Annales Pharmaceutiques Françaises. 82(5). 762–764.

Boulin, Mathieu, Claire Falandry, Laure de Decker, et al.. (2023). Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO. Critical Reviews in Oncology/Hematology. 190. 104117–104117. 5 indexed citations

Maistre, Emmanuel de, et al.. (2023). Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021. International Journal of Environmental Research and Public Health. 20(2). 1448–1448. 2 indexed citations

Boulin, Mathieu, et al.. (2023). Patients sous anticancéreux : pratiques et attentes des pharmaciens officinaux. Bulletin du Cancer. 111(2). 176–189. 2 indexed citations

Bouillet, Benjamin, Isabelle Simoneau, Sylvain Manfrédi, et al.. (2023). Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring. Acta Diabetologica. 60(4). 545–552. 3 indexed citations

Boulin, Mathieu, Karine Le Malicot, Julien Taı̈eb, et al.. (2022). Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma. The Oncologist. 27(7). e571–e579. 3 indexed citations

Boulin, Mathieu, Amélie Cransac, Marc Maynadié, et al.. (2022). COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 19(7). 3957–3957. 5 indexed citations

Chagué, F., Mathieu Boulin, Jean‐Christophe Eicher, et al.. (2022). Smoking in Patients With Chronic Cardiovascular Disease During COVID-19 Lockdown. Frontiers in Cardiovascular Medicine. 9. 845439–845439. 2 indexed citations

Chagué, F., Mathieu Boulin, F. Bichât, et al.. (2021). Alarming increased rate of smoking and associated lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 pandemic related lockdown. Archives of Cardiovascular Diseases Supplements. 13(1). 127–127. 5 indexed citations

10.

Aho, Serge, et al.. (2020). Better survival in impaired renal function patients with metastatic non-small cell lung cancer treated by cisplatin-pemetrexed. European Journal of Clinical Pharmacology. 76(11). 1573–1580. 4 indexed citations

11.

Zeller, Marianne, F. Chagué, F. Bichât, et al.. (2020). Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb. International Journal of Cardiology. 323. 285–287. 37 indexed citations

12.

Quenot, Jean‐Pierre, Julie Helms, Abderrahmane Bourredjem, et al.. (2019). Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial. Annals of Intensive Care. 9(1). 75–75. 20 indexed citations

13.

Guiu, Boris, P. Chevallier, Eric Assénat, et al.. (2019). Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial. Radiology. 291(3). 801–808. 27 indexed citations

14.

Cransac, Amélie, Serge Aho, Marie‐Lorraine Chrétien, et al.. (2019). Adherence to immunomodulatory drugs in patients with multiple myeloma. PLoS ONE. 14(3). e0214446–e0214446. 19 indexed citations

15.

Anota, Amélie, Mathieu Boulin, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2016). An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma. BMJ Open. 6(6). e010696–e010696. 11 indexed citations

16.

Boulin, Mathieu, Vakaramoko Diaby, & Cara Tannenbaum. (2016). Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada. PLoS ONE. 11(9). e0162951–e0162951. 16 indexed citations

17.

Anota, Amélie, Franck Bonnetain, C Pernot, et al.. (2016). Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies. Annales Pharmaceutiques Françaises. 74(6). 439–447. 3 indexed citations

18.

Boulin, Mathieu, Boris Guiu, Serge Aho, et al.. (2012). Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patients. Diagnostic and Interventional Imaging. 94(1). 53–59. 9 indexed citations

19.

Boulin, Mathieu, Boris Guiu, E. Maillard, et al.. (2011). Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma. Digestive and Liver Disease. 43(11). 905–911. 9 indexed citations

20.

Guiu, Boris, Frédèric Deschamps, Mathieu Boulin, et al.. (2011). Serum Gamma-Glutamyl-Transferase Independently Predicts Outcome After Transarterial Chemoembolization of Hepatocellular Carcinoma: External Validation. CardioVascular and Interventional Radiology. 35(5). 1102–1108. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact